Literature DB >> 8574284

Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies.

T Akamizu1, L D Kohn, T Mori.   

Abstract

Cloning of TSHR gene and some subsequent studies using the gene were described. Enormous numbers of studies have been performed since the cloning of TSHR gene. Recent molecular studies on TSH receptor and TSHRAb gave various impacts on thyroidology and are resolving past problems. We mainly focused on regulation, processing and glycosylation, TSH- and TSHRAb binding sites, T cell epitopes, and signal transduction of TSHR. Furthermore, we isolated and characterized TSHRAb genes using lymphocytes producing monoclonal TSHRAb obtained from patients with Graves' disease and primary hypothyroidism. Thus, both antigen and antibody genes are cloned. Combined use of these genes will help to investigate the interactions between TSHR and TSHRAb, and may be expected to contribute to the understanding of molecular mechanisms underlying the pathogenesis of autoimmune thyroid disease as well as the physiology of the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574284     DOI: 10.1507/endocrj.42.617

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema.

Authors:  K Moriyama; J Okuda; M Saijo; Y Hattori; N Kanamoto; Y Hataya; F Matsuda; T Mori; K Nakao; T Akamizu
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

Review 2.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

Review 3.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.